|
2006
11/14/06
Corgenix
Reports Revenue for First Quarter of Fiscal 2007
10/24/06
Corgenix
to Present at Rodman and Renshaw TechVest 8th annual Healthcare Conference on
November 8, 2006
09/28/06
Corgenix
Reports Record Sales For Fiscal 2006
08/21/06
Aspirin
Resistance Test Licensed to Corgenix Receives US Patent Office Approval
07/20/06
Corgenix
Submits FDA Premarket of AspirinWorks Test Kit
07/18/06
Corgenix
Expands Operations in US and Europe
07/06/06
Corgenix
Launches Diagnostic Test for Aspirin Effectiveness
05/15/06
Corgenix
Reports Third Quarter Fiscal 2006 Results
03/31/06
Corgenix
Appoints One of Country's Experts in Healthcare Financing to Board of Directors
03/29/06
Corgenix
Submits 510(k) Filing For AtherOx, A Next-Generation Predictive Cardiovascular
Diagnostic Line
03/28/06
Corgenix
Appoints Two Independent Industry and Finance Veterans to Board of Directors and
Announces the Formal Closing of the Sale of Preferred Shares
02/14/06
Corgenix,
Developer and Manufacturer of In-Vitro Diagnostic Products, Hosts Second Quarter
2006 Earnings Conference Call
02/14/06
Corgenix
Reports Second Quarter Fiscal 2006 Results
01/03/06
Corgenix
Executes Private Placement Agreements Representing Initial Gross Proceeds of
$3.36 Million
02/02/06
Corgenix
and Rebio Gen, Inc. Sign Extension to Technology Agreement for Hyaluronic
Acid
2005
11/10/05
Corgenix
Reports Record Sales and EBITDA for First Quarter of Fiscal 2006
11/09/05
Corgenix
to Develop Diagnostic Tests for Bio-Terrorism Agents Under Multi-Million Dollar
NIH Contract Awarded to Tulane University
10/10/05
Corgenix
Named One of Fastest Growing Technology Companies in Colorado According to
Deloitte and Touche
09/23/05
Corgenix
Reports Record Sales for Fiscal 2005
09/12/05
Corgenix
Launches Next Generation Predictive Cardiovascular Diagnostic Line
07/26/05
Corgenix
Adds Seasoned Biomedical Veterans to Management Team
06/08/05
Corgenix
Medical Corporation Retains New York Based Investor Relations Firm
05/12/05
Corgenix
Announces Third Quarter Results
01/26/05
Corgenix
Announces Establishment of Bio-Terrorism Defense Development Program
01/18/05
Corgenix
Engages Ascendiant Securities for Investment Banking Services
01/14/05
Corgenix
Announces Termination of Its Proposed Merger With Genesis Bioventures, Inc.
2004
11/15/04
Corgenix
Announces First Quarter Results and Merger Update
11/08/04
Collaboration
for Aspirin Resistance Testing Announced by Corgenix Medical Corp., Creative
Clinical Concepts, Inc. and McMaster University
10/14/04
Corgenix
Announces Record Revenues in Fiscal 2004
08/19/07
Corgenix
and Autoimmune Technologies Complete Development of Diagnostic Product for
Fibromyalgia
05/12/04
Corgenix
Announces Third Quarter Results
03/16/04
Corgenix
Medical Corporation and Genesis Bioventures Announce Signing of Merger Agreement
and Completion of $2 Million Initial Financing Round
2003
11/13/03
Corgenix
Announces First Quarter Results and Merger Update
10/30/03
Corgenix
Receives FDA Clearance to Market 11 Diagnostic Tests for Risk of Cardiovascular
Disease
10/15/03
Corgenix
Announces Fiscal Year Results
10/01/03
Corgenix
Medical Corporation Announces Merger Update
08/05/03
Corgenix
Medical Corporation to Merge with Genesis Bioventures
05/14/03
Corgenix
Announces Third Quarter Results
02/13/03
Corgenix
Announces Second Quarter Results
2002
12/12/02
Corgenix
Presents Fiscal Year 2002 Results and Discusses Future Growth at Shareholder
Meeting
11/22/02
Corgenix
Among Fastest Growing Companies in Colorado
11/15/02
Corgenix
Announces Record Revenues and Return to Profitability
10/02/02
Corgenix
Signs License Agreement
09/20/02
Corgenix
to Report Record Revenues from Core Business Operations
09/19/02
Corgenix
Announces Relationship with Ascendiant Capital Group
07/15/02
Corgenix
Receives Updated ISO and EN Certification
06/25/02
Corgenix
and Genesis Bioventures Announce Collaboration to Develop Commercialized Breast
Cancer Test
06/13/02
Corgenix
Announces Termination of Its Proposed Acquisition of Affinity Biologicals, Inc.
06/05/02
Corgenix
on Track to Complete Acquisition of Affinity Biologicals, Inc.
05/15/02
Corgenix
Reports Third Quarter Results
04/05/02
Corgenix
Withdraws Application for Rheumatoid Arthritis Test Clearance--Will Emphasize
Program for Liver Disease
03/25/02
Corgenix
Medical Corporation Retains Financial Public Relations Firm
03/21/02
Corgenix
Signs Distribution Agreement with RhiGene
02/12/02
Corgenix
Reports Second Quarter Results
01/14/02
Corgenix
to Trade Under New Symbol--CONX
01/09/02
Corgenix
Medical Corporation to Acquire Affinity Biologicals, Inc.
2001
07/09/01
Corgenix
Submits Application to the FDA for Hyualuronic Acid Test Kit
06/25/01
Corgenix
and Chugai Diagnostics Science Sign Technology License
06/20/01
Corgenix
Announces Its Intention to Seek Shareholder Approval to Authorize Reverse Stock
Split
05/09/01
Corgenix
Announces Record Revenues for the Third Quarter and Fiscal Year to Date
05/02/01
Corgenix
Invites You to Join Its Third Quarter 2001 Earnings Conference Call on the Web
04/17/01
Corgenix
Receives FDA Clearance for New Diagnostic Products - Two Additional Tests Now
Available to Assess Risk of Thrombosis
04/16/01
Corgenix
Retains Bathgate McColley Capital Group, LLC
04/12/01
Corgenix
Announces Participation in Knobias.com "Corporate Tour 1000" Campaign
03/21/01
Corgenix
Announces Board Change
02/26/01
Corgenix Submits Two
Applications to the FDA for Newly Developed Products
02/05/01
Corgenix
Presents Fiscal Year 2000 Results
01/31/01
Corgenix
Announces Preliminary Second Quarter Results
12/13/01
Corgenix
Announces Expansion of Board of Directors
12/12/01
Corgenix
Presents Fiscal Year 2001 Results and Discusses Future Growth at Shareholder's
Meeting
11/14/01
Corgenix
Announces Record Revenues for the First Quarter
10/01/01
Corgenix
Announces Record Revenue and Income Results for Fiscal Year 2001
2000
11/14/00
Corgenix
Reports Financial Results for First Quarter
10/03/00
Corgenix
Announces Record Results for Fiscal Year 2000
07/13/00
Corgenix
Announces Preliminary Fourth Quarter Results
05/11/00
Corgenix
Announces Record Results
05/10/00
Corgenix
Receives FDA Clearance to Market an Important New Product
02/24/00
Corgenix Expands UK
Operations and Signs New Distribution Agreements
02/10/00
Corgenix Announces
Record Results for Second Quarter
1999
1998
11/10/98
Corgenix
Submits Filing to FDA for Clearance of New Test for Measuring Protein S
Deficiency
09/22/98
Corgenix
Medical Corporation to Acquire Integrated Diagnostics, Inc.
09/16/98
Corgenix
Becomes a Reporting Company
08/26/98
Corgenix
Signs Distribution Agreement with American Biogenetic Sciences
| 
